financetom
Business
financetom
/
Business
/
Hub Cyber Security Powers Up: Major Debt Reduction, Fresh Investment, Board Change & More
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hub Cyber Security Powers Up: Major Debt Reduction, Fresh Investment, Board Change & More
Nov 29, 2024 8:19 AM

Hub Cyber Security Ltd. ( HUBC ) shares are trading higher on Friday.

The company has reached an agreement with AGP to reduce its $5.7 million convertible note obligations by 70%, signaling a significant reduction in its overall debt.

This effort is part of Hub Cyber Security’s broader strategy to bolster its balance sheet and position itself for long-term success.

In addition, the company has secured an additional $1 million investment from a private investor who has previously committed a total of $10 million to the company.

This capital infusion will support the company’s growth and key initiatives heading into the end of the year. HUB Security is also in the process of refinancing another $7.5 million of debt into a long-term settlement, further strengthening its financial foundation.

Also Read: Black Friday Frenzy: Shoppers Queue For Taylor Swift Merch, Retro Gadgets And More As Retailers Open Doors Early Amid Shortened Shopping Season

Also, the company stated that Renah Persofsky will join its Board of Directors, replacing Lior Lurye. Persofsky has served on multiple boards of both Nasdaq-listed and unlisted private companies and brings vast business experience.

“As we move forward, HUB Security remains steadfast in its mission to deliver exceptional value to our stakeholders, drive innovation in Secured Data Fabric solutions, and expand our leadership in the global cybersecurity landscape,” said Noah Hershcoviz, CEO of HUB Cyber Security ( HUBC ).

Price Action: HUBC shares are trading higher by 4.29% to $0.5397 at last check Friday.

Read Next: 

Sheinbaum To Trump: ‘Neither Threats Nor Tariffs' Will Solve Your Fentanyl Crisis

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved